Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.
Showing 351-360 of 555 results
Molecular Pain, 2018 • November 12, 2018
This study used RNA-seq to identify gene expression changes in the spinal cord of nerve-injured rats after repetitive conventional spinal cord stimulation (SCS) treatment. The RNA-seq data suggest fur...
KEY FINDING: Repetitive SCS further increases many existing upregulated immune responses in chronic constrictive injury rats, including transcription of cell surface receptors and activation of non-neuronal cells.
Neuromodulation, 2019 • February 1, 2019
The study aimed to determine whether sub-sensory threshold SCS of lower frequencies can also inhibit mechanical hypersensitivity in nerve-injured rats and examine how electric charge delivery of stimu...
KEY FINDING: Both high (10 kHz) and lower frequencies (200 Hz, 500 Hz, 1200 Hz) of subthreshold SCS attenuated mechanical hypersensitivity in nerve-injured rats.
The Journal of Neuroscience, 2019 • February 13, 2019
The study demonstrates that repeated social defeat (RSD) stress promotes a neuroinflammatory environment in the spinal cord, leading to increased pain sensitivity (mechanical allodynia) in mice. Micro...
KEY FINDING: Repeated social defeat (RSD) stress increases mechanical allodynia (pain sensitivity) in mice.
Neuroscience Bulletin, 2019 • December 17, 2018
This review assesses the use of spinal cord stimulation (SCS) for the treatment of chronic pain after spinal cord injury (SCI). While restoring motor and other functions is important, alleviating pain...
KEY FINDING: Conventional SCS may be more effective for reducing pain in patients with incomplete SCI, particularly those with lesions at low thoracic to upper lumbar levels.
Neural Regen Res, 2019 • May 1, 2019
This study investigated the role of neural stem cell (NSC) transplantation in P2X receptor-mediated neuropathic pain in spinal cord injury (SCI) rats. The results showed that NSC transplantation reduc...
KEY FINDING: Neural stem cell transplantation markedly increased neurofilament protein expression in the injured spinal cord segment 4 weeks post-transplantation.
Medicine, 2019 • February 1, 2019
This study reports two cases of patients with mild TBI who developed headaches due to injury of the spinothalamic tract (STT). Diffusion tensor tractography (DTT) revealed narrowing or discontinuation...
KEY FINDING: DTT scans revealed narrowing of the spinothalamic tract (STT) in both hemispheres of both patients.
Spinal Cord Series and Cases, 2019 • January 24, 2019
The study assessed the international spinal cord medicine and rehabilitation community’s utilization of pharmacological and non-pharmacological treatments for spinal cord damage (SCD)-related pain. Mo...
KEY FINDING: Most spinal cord medicine clinicians employ a multimodal approach to pain, indicating that individualized and multimodal strategies are common.
Frontiers in Neurology, 2019 • February 14, 2019
The study examined the relationship between behavioral changes to tonic heat and changes in neuropathic pain severity in patients with spinal cord injury. The primary finding was that changes in the s...
KEY FINDING: There was no initial correlation between responses to tonic heat and neuropathic pain severity upon admission to rehabilitation.
Exp Neurol, 2019 • August 1, 2019
The study examined the effect of hindlimb stretching on locomotor function in rats with spinal cord injury (SCI), focusing on the role of nociceptive afferents. Results showed that stretching reduced ...
KEY FINDING: Stretching-induced drops in locomotor function were observed in nociceptor-intact animals but were nearly absent in nociceptor-depleted animals.
BMC Neurology, 2019 • March 14, 2019
This study aimed to quantitatively analyze the clinical effectiveness of motor cortex stimulation (MCS) for refractory pain by systematically reviewing relevant literature. The pooled effect estimate ...
KEY FINDING: MCS shows a positive effect on refractory pain, with a total percentage improvement of 35.2% in post-stroke pain and 46.5% in trigeminal neuropathic pain.